Publicacións en colaboración con investigadores/as de Hospital de la Santa Creu i Sant Pau (15)

2024

  1. Functioning in schizophrenia: Recommendations of an expert panel

    Schizophrenia Research, Vol. 270, pp. 317-322

2023

  1. Aripiprazole for the treatment of schizophrenia: Recommendations of a panel of Spanish experts on its use in clinical practice

    International Journal of Psychiatry in Clinical Practice, Vol. 27, Núm. 1, pp. 82-91

2021

  1. Identifying clinical clusters with distinct trajectories in first-episode psychosis through an unsupervised machine learning technique

    European Neuropsychopharmacology, Vol. 47, pp. 112-129

  2. Structure and functioning of acute inpatient psychiatric units in Spain: Qualitative study

    JMIR Research Protocols, Vol. 10, Núm. 4

2016

  1. A path analysis of patient dependence and caregiver burden in Alzheimer's disease

    International Psychogeriatrics, Vol. 28, Núm. 7, pp. 1133-1141

2015

  1. Efficiency of pragmatic search strategies to update clinical guidelines recommendations

    BMC Medical Research Methodology, Vol. 15, Núm. 1

  2. Modeling the longitudinal latent effect of pregabalin on self-reported changes in sleep disturbances in outpatients with generalized anxiety disorder managed in routine clinical practice

    Drug Design, Development and Therapy, Vol. 9, pp. 4329-4340

2014

  1. Replication of previous genome-wide association studies of psychiatric diseases in a large schizophrenia case-control sample from Spain

    Schizophrenia Research, Vol. 159, Núm. 1, pp. 107-113

2013

  1. Modelling the cost-effectiveness of pregabalin versus usual care in daily practice in the treatment of refractory generalised anxiety disorder in Spain

    Social Psychiatry and Psychiatric Epidemiology, Vol. 48, Núm. 6, pp. 985-996

2012

  1. Broadening of generalized anxiety disorders definition does not affect the response to psychiatric care: Findings from the observational ADAN study

    Clinical Practice and Epidemiology in Mental Health, Vol. 8, pp. 158-168

  2. Pregabalin versus SSRIs and SNRIs in benzodiazepine-refractory outpatients with generalized anxiety disorder: A post hoc cost-effectiveness analysis in usual medical practice in Spain

    ClinicoEconomics and Outcomes Research, Vol. 4, Núm. 1, pp. 157-168

2010

  1. Rendimiento psicométrico de la sexta versión del Addiction Severity Index en español (ASI-6)

    Psicothema, Vol. 22, Núm. 3, pp. 513-519

2007

  1. Effect of olanzapine or risperidone treatment on some cognitive functions in a one-year follow-up of schizophrenia outpatients with prominent negative symptoms

    European Neuropsychopharmacology, Vol. 17, Núm. 11, pp. 725-734

2006

  1. A randomized, 1-year follow-up study of olanzapine and risperidone in the treatment of negative symptoms in outpatients with schizophrenia

    Journal of Clinical Psychopharmacology, Vol. 26, Núm. 3, pp. 238-249

  2. Improvement in social functioning in outpatients with schizophrenia with prominent negative symptoms treated with olanzapine or risperidone in a 1 year randomized, open-label trial

    Progress in Neuro-Psychopharmacology and Biological Psychiatry, Vol. 30, Núm. 8, pp. 1515-1522